Cargando…

The uptake and effectiveness of online cognitive behaviour therapy for symptoms of anxiety and depression during COVID-19

BACKGROUND: The mental health impacts of COVID-19 have been considerable with many individuals experiencing significant anxiety and depression. Online cognitive behavioural therapy (iCBT) programs provide scalable access to psychological interventions, however the effectiveness of these programs dur...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahoney, Alison, Li, Ian, Haskelberg, Hila, Millard, Michael, Newby, Jill M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177308/
https://www.ncbi.nlm.nih.gov/pubmed/34126311
http://dx.doi.org/10.1016/j.jad.2021.05.116
_version_ 1783703369801531392
author Mahoney, Alison
Li, Ian
Haskelberg, Hila
Millard, Michael
Newby, Jill M
author_facet Mahoney, Alison
Li, Ian
Haskelberg, Hila
Millard, Michael
Newby, Jill M
author_sort Mahoney, Alison
collection PubMed
description BACKGROUND: The mental health impacts of COVID-19 have been considerable with many individuals experiencing significant anxiety and depression. Online cognitive behavioural therapy (iCBT) programs provide scalable access to psychological interventions, however the effectiveness of these programs during the pandemic has not been investigated. This study examined the uptake and effectiveness of iCBT for symptoms of anxiety and depression during the first eight months of the pandemic in Australia (March- October 2020) and compared outcomes to the 12 months prior to COVID-19. METHODS: 6,132 adults commenced iCBT (5,074 during the pandemic and 1,058 in the year before) and completed measures of anxiety and depression symptom severity, and psychological distress pre- and post-treatment. RESULTS: In the COVID-19 period, we observed a 504% increase in the number of monthly course registrations compared to the year prior (with a peak increase of 1,138% between April and June 2020). Baseline anxiety and depression symptom severity were similar for the COVID and pre-COVID groups. Prior to and during the pandemic, the iCBT course was associated with large effect size reductions in anxiety (g = 0.94–1.18) and depression (g = 0.92–1.12) symptom severity, as well as psychological distress (g = 1.08–1.35). LIMITATIONS: lack of control group and long-term follow-up, as well as lack of detailed information about course users (e.g., health status and life context). CONCLUSION: Results indicate the considerable increase in demand for psychological support during the COVID-19 pandemic in Australia and demonstrate the effectiveness and scalability of iCBT for symptoms of anxiety and depression.
format Online
Article
Text
id pubmed-8177308
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-81773082021-06-05 The uptake and effectiveness of online cognitive behaviour therapy for symptoms of anxiety and depression during COVID-19 Mahoney, Alison Li, Ian Haskelberg, Hila Millard, Michael Newby, Jill M J Affect Disord Research Paper BACKGROUND: The mental health impacts of COVID-19 have been considerable with many individuals experiencing significant anxiety and depression. Online cognitive behavioural therapy (iCBT) programs provide scalable access to psychological interventions, however the effectiveness of these programs during the pandemic has not been investigated. This study examined the uptake and effectiveness of iCBT for symptoms of anxiety and depression during the first eight months of the pandemic in Australia (March- October 2020) and compared outcomes to the 12 months prior to COVID-19. METHODS: 6,132 adults commenced iCBT (5,074 during the pandemic and 1,058 in the year before) and completed measures of anxiety and depression symptom severity, and psychological distress pre- and post-treatment. RESULTS: In the COVID-19 period, we observed a 504% increase in the number of monthly course registrations compared to the year prior (with a peak increase of 1,138% between April and June 2020). Baseline anxiety and depression symptom severity were similar for the COVID and pre-COVID groups. Prior to and during the pandemic, the iCBT course was associated with large effect size reductions in anxiety (g = 0.94–1.18) and depression (g = 0.92–1.12) symptom severity, as well as psychological distress (g = 1.08–1.35). LIMITATIONS: lack of control group and long-term follow-up, as well as lack of detailed information about course users (e.g., health status and life context). CONCLUSION: Results indicate the considerable increase in demand for psychological support during the COVID-19 pandemic in Australia and demonstrate the effectiveness and scalability of iCBT for symptoms of anxiety and depression. Elsevier B.V. 2021-09-01 2021-06-04 /pmc/articles/PMC8177308/ /pubmed/34126311 http://dx.doi.org/10.1016/j.jad.2021.05.116 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Paper
Mahoney, Alison
Li, Ian
Haskelberg, Hila
Millard, Michael
Newby, Jill M
The uptake and effectiveness of online cognitive behaviour therapy for symptoms of anxiety and depression during COVID-19
title The uptake and effectiveness of online cognitive behaviour therapy for symptoms of anxiety and depression during COVID-19
title_full The uptake and effectiveness of online cognitive behaviour therapy for symptoms of anxiety and depression during COVID-19
title_fullStr The uptake and effectiveness of online cognitive behaviour therapy for symptoms of anxiety and depression during COVID-19
title_full_unstemmed The uptake and effectiveness of online cognitive behaviour therapy for symptoms of anxiety and depression during COVID-19
title_short The uptake and effectiveness of online cognitive behaviour therapy for symptoms of anxiety and depression during COVID-19
title_sort uptake and effectiveness of online cognitive behaviour therapy for symptoms of anxiety and depression during covid-19
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177308/
https://www.ncbi.nlm.nih.gov/pubmed/34126311
http://dx.doi.org/10.1016/j.jad.2021.05.116
work_keys_str_mv AT mahoneyalison theuptakeandeffectivenessofonlinecognitivebehaviourtherapyforsymptomsofanxietyanddepressionduringcovid19
AT liian theuptakeandeffectivenessofonlinecognitivebehaviourtherapyforsymptomsofanxietyanddepressionduringcovid19
AT haskelberghila theuptakeandeffectivenessofonlinecognitivebehaviourtherapyforsymptomsofanxietyanddepressionduringcovid19
AT millardmichael theuptakeandeffectivenessofonlinecognitivebehaviourtherapyforsymptomsofanxietyanddepressionduringcovid19
AT newbyjillm theuptakeandeffectivenessofonlinecognitivebehaviourtherapyforsymptomsofanxietyanddepressionduringcovid19
AT mahoneyalison uptakeandeffectivenessofonlinecognitivebehaviourtherapyforsymptomsofanxietyanddepressionduringcovid19
AT liian uptakeandeffectivenessofonlinecognitivebehaviourtherapyforsymptomsofanxietyanddepressionduringcovid19
AT haskelberghila uptakeandeffectivenessofonlinecognitivebehaviourtherapyforsymptomsofanxietyanddepressionduringcovid19
AT millardmichael uptakeandeffectivenessofonlinecognitivebehaviourtherapyforsymptomsofanxietyanddepressionduringcovid19
AT newbyjillm uptakeandeffectivenessofonlinecognitivebehaviourtherapyforsymptomsofanxietyanddepressionduringcovid19